Carol S. Portlock, MD

Attending, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

How should you treat a patient with lymphoma who developed “chemo brain” after R-CHOP therapy? Wednesday, November 1st, 2017
This month, Carol S. Portlock, MD, discusses neurologic toxicity following R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!

When should I order gene studies to establish clonality and rule out B-cell lymphoproliferative processes? Monday, June 1st, 2015
This month, Carol S. Portlock, MD, advises on gene studies to establish clonality in B-cell lymphoproliferative disorders.